Paraganglioma of the carotid body: treatment strategy and SDH-gene mutations.

[1]  J. Hornick,et al.  Succinate Dehydrogenase-deficient Tumors: Diagnostic Advances and Clinical Implications , 2012, Advances in anatomic pathology.

[2]  I. Mader,et al.  Head and neck paragangliomas: clinical and molecular genetic classification , 2012, Clinics.

[3]  S. Hodgson,et al.  Clinicoradiological manifestations of paraganglioma syndromes associated with succinyl dehydrogenase enzyme mutation , 2011, Insights into imaging.

[4]  P. Walker,et al.  Important observations made managing carotid body tumors during a 25-year experience. , 2010, Journal of vascular surgery.

[5]  J. Bayley,et al.  Recent advances in the genetics of SDH-related paraganglioma and pheochromocytoma , 2010, Familial Cancer.

[6]  E. van Marck,et al.  An immunohistochemical procedure to detect patients with paraganglioma and phaeochromocytoma with germline SDHB, SDHC, or SDHD gene mutations: a retrospective and prospective analysis. , 2009, The Lancet. Oncology.

[7]  S. Kakkos,et al.  Contemporary presentation and evolution of management of neck paragangliomas. , 2009, Journal of vascular surgery.

[8]  G. Rasp,et al.  Clinical predictors for germline mutations in head and neck paraganglioma patients: cost reduction strategy in genetic diagnostic process as fall-out. , 2009, Cancer research.

[9]  L. Serrano,et al.  High frequency of germline succinate dehydrogenase mutations in sporadic cervical paragangliomas in northern Spain: mitochondrial succinate dehydrogenase structure-function relationships and clinical-pathological correlations. , 2007, The Journal of clinical endocrinology and metabolism.

[10]  O. Haas,et al.  Novel SDHD germ‐line mutations in pheochromocytoma patients , 2007, European journal of clinical investigation.

[11]  C. Eng,et al.  Distinct clinical features of paraganglioma syndromes associated with SDHB and SDHD gene mutations. , 2004, JAMA.

[12]  J. Benítez,et al.  Identification of novel SDHD mutations in patients with phaeochromocytoma and/or paraganglioma , 2002, European Journal of Human Genetics.

[13]  S. Lahiri,et al.  Lessons from chronic intermittent and sustained hypoxia at high altitudes , 2002, Respiratory Physiology & Neurobiology.

[14]  D. Frank,et al.  Combined endovascular and surgical treatment of head and neck paragangliomas—A team approach , 2002, Head & neck.

[15]  J. Kuhn,et al.  Management of Carotid Body Paragangliomas and Review of a 30-Year Experience , 2002, Annals of vascular surgery.

[16]  T. Komori,et al.  Carotid body tumour. , 2002, Oral oncology.

[17]  L. Karnell,et al.  National Cancer Data Base report on malignant paragangliomas of the head and neck , 2002, Cancer.

[18]  J. Milunsky,et al.  Novel mutations and the emergence of a common mutation in the SDHD gene causing familial paraganglioma. , 2001, American journal of medical genetics.

[19]  G. Cavallaro,et al.  Baroreflex failure syndrome after bilateral excision of carotid body tumors: an underestimated problem. , 2000, Journal of vascular surgery.

[20]  B. Devlin,et al.  Mutations in SDHD, a mitochondrial complex II gene, in hereditary paraganglioma. , 2000, Science.

[21]  B. Schick,et al.  Jugulotympanale Paragangliome: Therapiekonzepte in der Entwicklung* , 1998 .

[22]  J. Netterville,et al.  Carotid body tumors: A review of 30 patients with 46 tumors , 1995, The Laryngoscope.

[23]  S. Sheps,et al.  Carotid body tumor (chemodectoma). Clinicopathologic analysis of ninety cases. , 1971, American journal of surgery.

[24]  A. Rao,et al.  Carotid Body Tumour , 1959, The Journal of Laryngology & Otology.

[25]  G. Alderman.  National , 1896, The Journal of comparative medicine and veterinary archives.

[26]  A. Dietzek,et al.  Contiguous bilateral head and neck paragangliomas in a carrier of the SDHB germline mutation. , 2012, Journal of vascular surgery.

[27]  J. Schipper,et al.  Clinical features of paraganglioma syndromes. , 2009, Skull base : official journal of North American Skull Base Society ... [et al.].